While correlations between serum levels of IGFBP3 and breast cancer have yielded contradictory results [19], [20], [21], [26], increased levels of IGFBP3 in breast cancer tissue is correlated with a worse prognosis and poor clinical features [17], [18]. This evidence concerns the gene IGFBP3 and breast cancer.